Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA)

M. BOOF (ALLSCHWIL, Switzerland), I. Fietze (BERLIN, Germany), K. Lederer (BERLIN, Germany), M. Ufer (ALLSCHWIL, Switzerland), J. Dingemanse (ALLSCHWIL, Switzerland)

Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Session: Treatment of obstructive sleep apnoea and its effects
Session type: E-poster session
Number: 2149
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. BOOF (ALLSCHWIL, Switzerland), I. Fietze (BERLIN, Germany), K. Lederer (BERLIN, Germany), M. Ufer (ALLSCHWIL, Switzerland), J. Dingemanse (ALLSCHWIL, Switzerland). Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA). 2149

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003

Role of CPAP treatment in elderly with moderate obstructive sleep apnea
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019


The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Comparison of auto-adjusting and fixed positive airway pressure therapy in patients with mild to moderate obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 95s
Year: 2003

Fibrinogen level in patients with severe obstructive sleep apnoea syndrome (OSAS). Effect of n-CPAP therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 216s
Year: 2001

Chronic respiratory failure in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005

Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009

The clinical significance nocturnal hypoventilation (NH) in patients with severe obstructive sleep apnoea (OSA)
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020


Effect of nCPAP on work performance (WP) in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 725s
Year: 2005

CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

Degree of sleepiness and cardiac alterations in non-hypertensive obstructive sleep apnea (OSA) patients
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009


Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Telecoaching to improve physical activity in patients with obstructive sleep apnea treated with CPAP
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011

PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012

Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome?
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Nicotine dependence in tunisian patients with severe obstructive sleep apnea (OSA)
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009


Effect of obstructive sleep apnea on asthma control
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011